至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Wars2 is a determinant of angiogenesis.

Nat Commun. 2016; 
WangMao,SipsPatrick,KhinEster,RotivalMaxime,SunXiming,AhmedRizwan,WidjajaAnissa Anindya,SchaferSebastian,YusoffPermeen,ChoksiPervinder Kaur,KoNicole Shi Jie,SinghManvendra K,EpsteinDavid,GuanYuguang,HouštěkJosef,MracekTomas,NuskovaHana,MikellBrittney,TanJessie,PesceFrancesco,KolarFrantisek,BottoloLeonardo,ManciniMassimiliano,HubnerNorbert,PravenecMichal,PetrettoEnrico,MacRaeCalum,CookStua
Products/Services Used Details Operation

摘要

Coronary flow (CF) measured ex vivo is largely determined by capillary density that reflects angiogenic vessel formation in the heart in vivo. Here we exploit this relationship and show that CF in the rat is influenced by a locus on rat chromosome 2 that is also associated with cardiac capillary density. Mitochondrial tryptophanyl-tRNA synthetase (Wars2), encoding an L53F protein variant within the ATP-binding motif, is prioritized as the candidate at the locus by integrating genomic data sets. WARS2(L53F) has low enzyme activity and inhibition of WARS2 in endothelial cells reduces angiogenesis. In the zebrafish, inhibition of wars2 results in trunk vessel deficiencies, disordered endocardial-myocardial... More

关键词